Cardiac sympathetic activity in 22q11.2 deletion syndrome.

[1]  K. Choy,et al.  Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnancies , 2015, Prenatal diagnosis.

[2]  Brian Chung,et al.  Practical guidelines for managing adults with 22q11.2 deletion syndrome , 2015, Genetics in Medicine.

[3]  B. Kolachana,et al.  Biological Effects of COMT Haplotypes and Psychosis Risk in 22q11.2 Deletion Syndrome , 2014, Biological Psychiatry.

[4]  D. Le Guludec,et al.  Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  M. Cerqueira,et al.  Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. , 2010, Journal of the American College of Cardiology.

[6]  Kenichi Nakajima,et al.  Normal values for nuclear cardiology: Japanese databases for myocardial perfusion, fatty acid and sympathetic imaging and left ventricular function , 2010, Annals of nuclear medicine.

[7]  J. Husted,et al.  Premature death in adults with 22q11.2 deletion syndrome , 2009, Journal of Medical Genetics.

[8]  L. Brewster,et al.  Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. , 2008, European heart journal.

[9]  F. Baas,et al.  Disrupted Dopaminergic Neurotransmission in 22q11 Deletion Syndrome , 2008, Neuropsychopharmacology.

[10]  K. Sullivan,et al.  Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome/velocardiofacial Syndrome. , 2008, Immunology and allergy clinics of North America.

[11]  T. van Amelsvoort,et al.  AMPT-induced monoamine depletion in humans: evaluation of two alternative [123I]IBZM SPECT procedures , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[12]  T A Denton,et al.  Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. , 2000, Circulation.

[13]  D. Goldstein,et al.  Different relationships of spillover to release of norepinephrine in human heart, kidneys, and forearm. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[14]  D. Naber.  A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables , 1995, International clinical psychopharmacology.

[15]  J. Rabinovici,et al.  Endogenous catecholamines suppress thyrotropin secretion during the early follicular phase of the menstrual cycle. , 1995, The Journal of clinical endocrinology and metabolism.

[16]  B. Emanuel,et al.  Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1----q11.2. , 1992, Genomics.

[17]  I. Meredith,et al.  Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. , 1990, Physiological reviews.

[18]  G. Smythe,et al.  Direct pituitary inhibition of prolactin secretion by dopamine and noradrenaline in sheep. , 1989, The Journal of endocrinology.

[19]  A. Beck,et al.  An inventory for measuring clinical anxiety: psychometric properties. , 1988, Journal of consulting and clinical psychology.

[20]  R. Spielmann,et al.  Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. , 1988, Journal of the American College of Cardiology.

[21]  G. Simpson,et al.  A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS , 1970, Acta psychiatrica Scandinavica. Supplementum.

[22]  A. Wieck,et al.  Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. , 2004 .

[23]  K. Nakajima,et al.  Heterogeneity of cardiac sympathetic nerve activity and systolic dysfunction in patients with hypertrophic cardiomyopathy. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.